ArticleIndian dermatology online journal

Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic-General Recommendation Based on Available Evidence.

Dipankar De et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.